Page last updated: 2024-10-20

pyrazole and Fatty Liver

pyrazole has been researched along with Fatty Liver in 1 studies

1H-pyrazole : The 1H-tautomer of pyrazole.

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research Excerpts

ExcerptRelevanceReference
"However, CYP2A5 expression during nonalcoholic fatty liver disease (NAFLD) is still unknown."1.39Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease. ( Cao, Y; Guo, G; Li, R; Liu, F; Wang, Y; Zhang, X, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, R1
Guo, G1
Cao, Y1
Wang, Y1
Liu, F1
Zhang, X1

Other Studies

1 other study available for pyrazole and Fatty Liver

ArticleYear
Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease.
    Pharmacology, 2013, Volume: 92, Issue:1-2

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2A6; Cytochrome P450 Family 2; Diet, Hig

2013